Browse > Article
http://dx.doi.org/10.5352/JLS.2010.20.5.703

Deletion Polymorphism of UGT2B17 and Its Relation to Lung Cancer  

Lee, Se-Ra (Department of Biological Science, Dong-A University)
Ahn, Myoung-Hyun (Department of Biological Science, Dong-A University)
Seol, So-Young (Department of Biological Science, Dong-A University)
Lee, Ji-Sun (Department of Biological Science, Dong-A University)
Chung, Chung-Nam (Department of Biological Science, Dong-A University)
Leem, Sun-Hee (Department of Biological Science, Dong-A University)
Publication Information
Journal of Life Science / v.20, no.5, 2010 , pp. 703-709 More about this Journal
Abstract
Glucuronidation is a major pathway for NNAL [4-(methylnitrosamno)-1-(3-pyridyl)-1-butanol] and UGT2B17 (UGT, uridine diphospho-glucuronosyltransferase) is from the UGT2B family that glucuronidates carcinogens. UGT2B17 deletion was associated with decreased levels of NNAL and with increased risk of some cancers. The UGT2B17 gene varies in copy number from zero to two per individual in humans. To examine whether UGT2B17 gene deletion is associated with the risk of lung cancer, we investigated copy number variants (CNV) in 271 cancer-free controls and 176 cases of lung cancer in Koreans by a PCR-based method. The frequency of the UGT2B17 deleted alleles was much higher than in other Caucasian and African-American groups which have already been reported. While only up to 10% of Caucasians have zero copies of the gene, up to 74% of Koreans in this study showed that both copies of the gene were deleted. Furthermore, the overall frequency of this dual deletion in female groups was higher than in male groups. However, there was no association between CNV in UGT2B17 and lung cancer. This result suggested that the UGT2B17 deletion allele was not associated with the susceptibility of lung cancers in the Korean group. However, this UGT2B17 CNV polymorphism may be a useful marker for evolutionary analysis among races.
Keywords
UGTs; deletion polymorphism; CNV; breakpoint; evolution marker;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zheng, Z., J. L. Fang, and P. Lazarus. 2002. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab. Dispos. 30, 397-403.   DOI
2 Yang, T. L., X. D. Chen, Y. Guo, S. F. Lei, J. T. Wang, Q. Zhou, F. Pan, Y. Chen, Z. X. Zhang, S. S. Dong, X. H. Xu, H. Yan, X. Liu, C. Qiu, X. Z. Zhu, T. Chen, M. Li, H. Zhang, L. Zhang, B. M. Drees, J. J. Hamilton, C. J. Papasian, R. R. Recker, X. P. Song, J. Cheng, and H. W. Deng. 2008. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am. J. Hum. Genet. 83, 663-674.   DOI
3 Yoon, Y. H., S. Y. Seol, J. H. Heo, C. N. Chung, I. H. Park, and S. H. Leem. 2008. Analysis of VNTRs in the solute carrier family 6, member 18 (SLC6A18) and lack of association with hypertension. DNA and Cell Biology 27, 559-567.   DOI
4 Park, J., L. Chen, L. Ratnashinge, T. A. Sellers, J. P. Tanner, J. H. Lee, N. Dossett, N. Lang, F. F. Kadlubar, C. B. Ambrosone, B. Zachariah, R. V. Heysek, S. Patterson, and J. Pow-Sang. 2006. Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men. Cancer Epidermiol Biomarkers Prev. 15, 1473-1478.   DOI
5 Toschi, L. and F. Cappuzzo. 2007. Understanding the new genetics of responsiveness to epidermal growth factor receptor tyrosine kinase inhibitors. Oncologist 12, 211-220.   DOI
6 Tukey, R. H. and C. P. Strassburg. 2000. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev. Pharmacol. Toxicol. 40, 581-616.   DOI
7 Turgeon, D., J. S. Carrier, E. Levesque, B. G. Beatty, A. Belanger, and D. W. Hum. 2000. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J. Mol. Biol. 295, 489-504.   DOI
8 Wilson, W., F. Pardo-Manuel de Villena, B. D. Lyn-Cook, P. K. Chatterjee, T. A. Bell, D. A. Detwiler, R. C. Gilmore, I. C. Valladeras, C. C. Wright, D. W. Threadgill, and D. J. Grant. 2004. Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84, 707-714.   DOI
9 Mackenzie, P. I., I. S. Owens, B. Burchell, K. W. Bock, A. Bairoch, A. Bélanger, S. Fournel-Gigleux, M. Green, D. W. Hum, T. Iyanagi, D. Lancet, P. Louisot, J. Magdalou, J. R. Chowdhury, J. K. Ritter, H. Schachter, T. R. Tephly, K. F. Tipton, and D. W. Nebert. 1997. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7, 255-269.   DOI
10 Xue, Y., D. Sun, A. Daly, F. Yang, X. Zhou, M. Zhao, N. Huang, T. Zerjal, C. Lee, N. P. Carter, M. E. Hurles, and C. Tyler-Smith. 2008. Adaptive evolution of UGT2B17 copy-number variation. Am. J. Hum. Genet. 83, 337-346.   DOI
11 Mackenzie, P. I., K. W. Bock, B. Burchell, C. Guillemette, S. Ikushiro, T. Iyanagi, J. O. Miners, I. S. Owens, and D. W. Nebert. 2005. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15, 677-85.   DOI
12 Chen, G., R. W. Dellinger, D. Sun, T. E. Spratt, and P. Lazarus. 2008. Glucuronidation of tobacco-specific nitrosamines by UGT2B10. Drug Metab. Dispos. 36, 824-830.   DOI
13 Menard, V., O. Eap, M. Harvey, C. Guillemette, and E. Levesque. 2009. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism. Hum. Mutat. 30, 1310-1319.   DOI
14 Jemal, A., K. C. Chu, and R. E. Tarone. 2001. Recent trends in lung cancer mortality in the United States. J. Natl. Cancer Inst. 93, 277-283.   DOI
15 Kim, Y. C., Y. S. Kwon, I. J. Oh, K. S. Kim, S. Y. Kim, J. S. Ryu, H. K. Yum, S. J. Yong, K. H. Lee, C. G. Lee, S. Y. Lee, S. Y. Lee, M. H. Jung, E. T. Jeong, and K. H. In. 2007. National survey of lung cancer in Korea, 2005. J. Lung Cancer 6, 67-73.   DOI
16 Lazarus, P., Y. Zheng, E. A. Runkle, J. E. Muscat, and D. Wiener. 2005. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes. Pharmacogenet Genomics 15, 769-778.   DOI
17 Hirsch, F. R., M. V. Garcia, F. Cappuzzo, and et al. 2007. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann. Oncol. 18, 752-760.
18 Jakobsson, J., L. Ekstrom, N. Inotsume, M. Garle, M. Lorentzon, C. Ohlsson, H. K. Roh, K. Carlström, and A. Rane. 2006. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J. Clin. Endocrinol Metab. 91, 687-693.   DOI
19 Hecht, S. S., S. G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D. K. Hatsukami. 2008. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Cancer Epidemiol Biomarkers Prev. 17, 732-735.   DOI
20 Chakravarti, A. and A. Lynn. 2004. Meiotic mapping in human. In: Birren B., E. D. Green, S. Klapholz, R. M. Myers, Roskams (eds.), Genome analysis: A laboratory manual. Cold Spring Harber Laboratory Press, CSH, NewYork. Vol 4.
21 Chouinard, S., O. Barbier, and A. Bélanger. 2007. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J. Biol. Chem. 282, 33466-33474.   DOI
22 Gallagher, C. J., F. F. Kadlubar, J. E. Muscat, C. B. Ambrosone, N. P. Lang, and P. Lazarus. 2007. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev. 31, 310-315.   DOI
23 Bao, B. Y., B. F. Chuang, Q. Wang, O. Sartor, S. P. Balk, M. Brown, P. W. Kantoff, and G. S. Lee. 2008. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate 68, 839-848.   DOI
24 Gallagher, C. J., J. E. Muscat, A. N. Hicks, Y. Zheng, A. M. Dyer, G. A. Chase, J. Richie, and P. Lazarus. 2007. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiol Biomarkers Prev. 16, 823-828.   DOI
25 Guillemette, C. 2003. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J. 3, 136-158.   DOI
26 Beaulieu, M., E. Levesque, D. W. Hum, and A. Belanger. 1996. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J. Biol. Chem. 271, 22855-22862.   DOI